Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of UQCRFS1 mRNA | affects expression | 16483693
|
D020122 |
tert-Butylhydroperoxide |
Cyclosporine inhibits the reaction [[tert-Butylhydroperoxide co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein] | affects cotreatment|decreases phosphorylation|decreases reaction | 16023995
|
D020122 |
tert-Butylhydroperoxide |
[tert-Butylhydroperoxide co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein | affects cotreatment|decreases phosphorylation | 16023995
|
D002122 |
Calcium Chloride |
Calcium Chloride results in decreased phosphorylation of UQCRFS1 protein | decreases phosphorylation | 16023995
|
D002122 |
Calcium Chloride |
Cyclosporine inhibits the reaction [[oxophenylarsine co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein] | affects cotreatment|decreases phosphorylation|decreases reaction | 16023995
|
D002122 |
Calcium Chloride |
Cyclosporine inhibits the reaction [[tert-Butylhydroperoxide co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein] | affects cotreatment|decreases phosphorylation|decreases reaction | 16023995
|
D002122 |
Calcium Chloride |
[oxophenylarsine co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein | affects cotreatment|decreases phosphorylation | 16023995
|
D002122 |
Calcium Chloride |
[tert-Butylhydroperoxide co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein | affects cotreatment|decreases phosphorylation | 16023995
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UQCRFS1 mRNA | affects cotreatment|affects expression | 17602206
|
D016572 |
Cyclosporine |
Cyclosporine inhibits the reaction [[oxophenylarsine co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein] | affects cotreatment|decreases phosphorylation|decreases reaction | 16023995
|
D016572 |
Cyclosporine |
Cyclosporine inhibits the reaction [[tert-Butylhydroperoxide co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein] | affects cotreatment|decreases phosphorylation|decreases reaction | 16023995
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UQCRFS1 mRNA | affects cotreatment|affects expression | 17602206
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of UQCRFS1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of UQCRFS1 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UQCRFS1 mRNA | affects cotreatment|increases expression | 17942748
|
D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of UQCRFS1 mRNA | increases expression | 16807920
|
C029341 |
oxophenylarsine |
Cyclosporine inhibits the reaction [[oxophenylarsine co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein] | affects cotreatment|decreases phosphorylation|decreases reaction | 16023995
|
C029341 |
oxophenylarsine |
[oxophenylarsine co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein | affects cotreatment|decreases phosphorylation | 16023995
|
D010100 |
Oxygen |
UQCRFS1 protein affects the reaction [Oxygen deficiency results in increased expression of EPAS1 protein] | affects reaction|increases expression | 18353899
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of UQCRFS1 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UQCRFS1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of UQCRFS1 mRNA | increases expression | 20399798
|
C066340 |
tolcapone |
tolcapone binds to UQCRFS1 protein | affects binding | 19783845
|
D014212 |
Tretinoin |
[IFNB1 protein co-treated with Tretinoin] results in increased expression of UQCRFS1 protein | affects cotreatment|increases expression | 16826196
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.64 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.93 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.64 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.04 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
4.59 | 16759491 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.82 | 14692618 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.88 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.33 | 17162532 19061943 18056438 16434500 17620307 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.33 | 16835633 |
MESH:D017109 |
Akathisia, Drug-Induced |
|
tolcapone |
6.39 | 11080934 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.66 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
tolcapone |
3.29 | 20150427 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.00 | 11748828 |
MESH:D000860 |
Anoxia |
|
Oxygen |
5.14 | 20872349 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.54 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.31 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.31 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.27 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.36 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Oxygen |
3.83 | 16391483 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.47 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.12 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.12 | 16197459 16206674 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.80 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.36 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
2.36 | 17263869 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.36 | 16818667 16202921 19084267 11161223 15668708 16273361 17440819 18351453 19221464 19142967 19066611 19155303 19487384 20135344 19011961 19103187 19200415 19059307 17049068 18855134 20544844 18629630 19189212 17261762 19288272 19115204 18821012 18997820 20065188 19189210 21138602 20859285 18815881 21152245 18984771 19289846 20390343 17242785 19410462 17893378 15565566 16873071 18425577 19244106 20005174 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.36 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.36 | 16443354 16873071 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.67 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.58 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.26 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
4.64 | 18210153 19919837 19519916 17162532 19701751 19383236 16807293 16830150 19052882 18691550 18785209 20514400 17428255 16502159 19335982 20727157 20935162 16328049 20524982 18665156 21159647 10672840 19822196 16288022 3581430 19208518 18393292 17173139 19394651 19539802 20007298 18971187 3084413 11831363 20084675 16540662 18506893 18494052 19171122 10737359 18056438 17138121 18978308 16935385 20101231 20432363 16779866 19107877 17978847 17055752 16681979 16569478 16698587 16878318 20214788 17761372 20512989 19418558 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.64 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.64 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.30 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.66 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.39 | 18670907 18850075 16120746 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.12 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.73 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
6.73 | 2727394 21159647 17174075 7505956 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.67 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.49 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.49 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.91 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.91 | 17333356 16105132 11677210 16919318 17681005 15861022 17110522 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.26 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.83 | 15340226 12621046 15668235 8697196 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.83 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.78 | 17035595 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.11 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.46 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.46 | 9224671 10589399 9142499 9664655 9211117 9125849 16925845 17551590 14991402 8800419 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.43 | 19031437 |
MESH:D003866 |
Depressive Disorder |
|
tolcapone |
4.34 | 11224284 7768276 |
MESH:D003865 |
Depressive Disorder, Major |
|
tolcapone |
4.95 | 10440460 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.26 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.26 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.52 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.44 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.44 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
tolcapone |
6.44 | 19783845 16604736 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.80 | 11462148 |
MESH:D004409 |
Dyskinesia, Drug-Induced |
|
tolcapone |
5.50 | 11455177 |
MESH:D004417 |
Dyspnea |
|
Oxygen |
4.93 | 20016425 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.43 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.27 | 16714409 18230668 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.27 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.16 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.16 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.55 | 17893378 16202921 20544844 19155303 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.55 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.07 | 9294722 10568697 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.21 | 16302075 |
MESH:D054908 |
Extensively Drug-Resistant Tuberculosis |
|
tolcapone |
6.04 | 19578428 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.97 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.97 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
19.23 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
19.23 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
19.23 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
19.23 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.27 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.53 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.61 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.26 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
15.16 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.16 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
15.16 | 17994277 |
MESH:D005739 |
Gas Poisoning |
|
Oxygen |
5.31 | 20016425 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.30 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.04 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.69 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.22 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.26 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.62 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.62 | 9664655 14991402 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.50 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.39 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.96 | 12621046 16120746 15340226 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.14 | 16959395 15340226 8697196 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.25 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.64 | 16778211 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.01 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.01 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.88 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.52 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.52 | 17937319 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
8.43 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
8.43 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.43 | 12878042 12200463 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.84 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.12 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.12 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.54 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.37 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.45 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.45 | 18625569 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.79 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.75 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.08 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.19 | 19642359 16788101 17339181 16766008 9834237 15748426 17217047 16140955 19035177 19029980 17107899 17301526 17712046 16331271 17368321 16935935 12679006 17649720 16823087 19225113 19075265 17361223 17506722 16891316 17294898 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.34 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.19 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.85 | 20032147 18522880 19638242 18665156 18407596 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.48 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.48 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.48 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.11 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
10.88 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
10.88 | 2862719 19426721 20101389 18754104 20137499 19256749 19294768 20405173 12112319 19427195 12771043 18644402 18648771 10737359 21071580 9163691 20452335 19833225 19812893 21047994 21278145 16942905 21167192 20492335 19073162 20118626 15885732 19690152 19850985 20434301 15175105 20583210 19638242 18978307 19499222 19996281 19642983 19090486 18977376 19551842 19254457 2422723 19255062 20501860 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
10.88 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.88 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
5.87 | 18164116 18775883 18093689 19519916 17942915 18282651 3124819 19004024 18253720 18544905 19126423 17174075 9362446 19009564 21159647 18308698 16842330 18079962 2563599 17854601 19539802 16267830 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.87 | 12151625 |
MESH:D055370 |
Lung Injury |
|
Oxygen |
4.58 | 18339021 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
3.40 | 20512841 20970405 21163286 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.40 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.40 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.84 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.66 | 14580682 11731420 19196722 16827153 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.64 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.80 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.31 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.31 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.26 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.50 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.88 | 16801185 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.11 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.06 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.80 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.80 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.53 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.43 | 16946489 16594593 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.10 | 19189210 19200415 19196722 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.54 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.33 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.73 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.73 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.09 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.39 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.21 | 20387270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.36 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.95 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.31 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.31 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.75 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
tolcapone |
3.61 | 11793426 7566641 9305320 11432539 9708959 11746615 9591521 8635184 17089403 1977408 20216409 19578428 10651109 9754991 9333106 18328768 16758261 8739811 19783845 20334432 11586115 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.35 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.62 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.10 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.10 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.27 | 11399792 11118676 11222880 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.14 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.66 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.39 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.88 | 16723453 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
4.57 | 17627322 18339021 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.90 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.16 | 16283617 16116481 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
9.57 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.57 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.57 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.89 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.89 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.12 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.43 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.43 | 17261132 |
MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
5.63 | 12563064 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.68 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.20 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.00 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.31 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.31 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.84 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.26 | 16040207 |
MESH:D018088 |
Tuberculosis, Multidrug-Resistant |
|
tolcapone |
6.04 | 19578428 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
2.37 | 8653321 17572228 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.73 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.36 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.71 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.08 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.69 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.59 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
tolcapone |
11.31 | 10573327 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
11.31 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.35 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.02 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.54 | 17120751 |